Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints.
Identifieur interne : 005264 ( Ncbi/Merge ); précédent : 005263; suivant : 005265Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints.
Auteurs : J. Tsevat ; I. Durand-Zaleski ; S G PaukerSource :
- American Journal of Public Health [ 0090-0036 ] ; 1989.
Abstract
We performed a cost-effectiveness analysis to evaluate whether patients with artificial joints should take penicillin, erythromycin, or no antibiotics before dental procedures. We modeled the risk of anaphylaxis from penicillin, the risks and consequences of an artificial joint infection, and the actual variable costs of hospitalization and antibiotics. Penicillin prophylaxis is slightly less expensive than erythromycin prophylaxis but is both more expensive and less effective than no prophylaxis. Erythromycin prophylaxis, the most effective, is the most expensive strategy. The marginal cost effectiveness of erythromycin prophylaxis compared to no prophylaxis is $12,900 per quality-adjusted year of life saved. Sensitivity analysis demonstrates that the risk of developing a joint infection is the key parameter in the analysis. Based on our estimated risk of developing a joint infection, the cost-effectiveness of antibiotic prophylaxis with erythromycin compares favorably with other medical interventions. Thus, until a definitive study to quantify the risk is conducted, patients with artificial joints should take prophylactic erythromycin when they undergo dental procedures.
Url:
PubMed: 2499200
PubMed Central: 1349634
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 001049
- to stream Pmc, to step Curation: 001049
- to stream Pmc, to step Checkpoint: 002911
Links to Exploration step
PMC:1349634Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints.</title>
<author><name sortKey="Tsevat, J" sort="Tsevat, J" uniqKey="Tsevat J" first="J" last="Tsevat">J. Tsevat</name>
</author>
<author><name sortKey="Durand Zaleski, I" sort="Durand Zaleski, I" uniqKey="Durand Zaleski I" first="I" last="Durand-Zaleski">I. Durand-Zaleski</name>
</author>
<author><name sortKey="Pauker, S G" sort="Pauker, S G" uniqKey="Pauker S" first="S G" last="Pauker">S G Pauker</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">2499200</idno>
<idno type="pmc">1349634</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1349634</idno>
<idno type="RBID">PMC:1349634</idno>
<date when="1989">1989</date>
<idno type="wicri:Area/Pmc/Corpus">001049</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001049</idno>
<idno type="wicri:Area/Pmc/Curation">001049</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001049</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002911</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002911</idno>
<idno type="wicri:Area/Ncbi/Merge">005264</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints.</title>
<author><name sortKey="Tsevat, J" sort="Tsevat, J" uniqKey="Tsevat J" first="J" last="Tsevat">J. Tsevat</name>
</author>
<author><name sortKey="Durand Zaleski, I" sort="Durand Zaleski, I" uniqKey="Durand Zaleski I" first="I" last="Durand-Zaleski">I. Durand-Zaleski</name>
</author>
<author><name sortKey="Pauker, S G" sort="Pauker, S G" uniqKey="Pauker S" first="S G" last="Pauker">S G Pauker</name>
</author>
</analytic>
<series><title level="j">American Journal of Public Health</title>
<idno type="ISSN">0090-0036</idno>
<idno type="eISSN">1541-0048</idno>
<imprint><date when="1989">1989</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>We performed a cost-effectiveness analysis to evaluate whether patients with artificial joints should take penicillin, erythromycin, or no antibiotics before dental procedures. We modeled the risk of anaphylaxis from penicillin, the risks and consequences of an artificial joint infection, and the actual variable costs of hospitalization and antibiotics. Penicillin prophylaxis is slightly less expensive than erythromycin prophylaxis but is both more expensive and less effective than no prophylaxis. Erythromycin prophylaxis, the most effective, is the most expensive strategy. The marginal cost effectiveness of erythromycin prophylaxis compared to no prophylaxis is $12,900 per quality-adjusted year of life saved. Sensitivity analysis demonstrates that the risk of developing a joint infection is the key parameter in the analysis. Based on our estimated risk of developing a joint infection, the cost-effectiveness of antibiotic prophylaxis with erythromycin compares favorably with other medical interventions. Thus, until a definitive study to quantify the risk is conducted, patients with artificial joints should take prophylactic erythromycin when they undergo dental procedures.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Public Health</journal-id>
<journal-title>American Journal of Public Health</journal-title>
<issn pub-type="ppub">0090-0036</issn>
<issn pub-type="epub">1541-0048</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">2499200</article-id>
<article-id pub-id-type="pmc">1349634</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints.</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Tsevat</surname>
<given-names>J</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Durand-Zaleski</surname>
<given-names>I</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Pauker</surname>
<given-names>S G</given-names>
</name>
</contrib>
</contrib-group>
<aff>Department of Medicine, Tufts University School of Medicine, Boston, MA 02111.</aff>
<pub-date pub-type="ppub"><month>6</month>
<year>1989</year>
</pub-date>
<volume>79</volume>
<issue>6</issue>
<fpage>739</fpage>
<lpage>743</lpage>
<abstract><p>We performed a cost-effectiveness analysis to evaluate whether patients with artificial joints should take penicillin, erythromycin, or no antibiotics before dental procedures. We modeled the risk of anaphylaxis from penicillin, the risks and consequences of an artificial joint infection, and the actual variable costs of hospitalization and antibiotics. Penicillin prophylaxis is slightly less expensive than erythromycin prophylaxis but is both more expensive and less effective than no prophylaxis. Erythromycin prophylaxis, the most effective, is the most expensive strategy. The marginal cost effectiveness of erythromycin prophylaxis compared to no prophylaxis is $12,900 per quality-adjusted year of life saved. Sensitivity analysis demonstrates that the risk of developing a joint infection is the key parameter in the analysis. Based on our estimated risk of developing a joint infection, the cost-effectiveness of antibiotic prophylaxis with erythromycin compares favorably with other medical interventions. Thus, until a definitive study to quantify the risk is conducted, patients with artificial joints should take prophylactic erythromycin when they undergo dental procedures.</p>
</abstract>
</article-meta>
</front>
</pmc>
<affiliations><list></list>
<tree><noCountry><name sortKey="Durand Zaleski, I" sort="Durand Zaleski, I" uniqKey="Durand Zaleski I" first="I" last="Durand-Zaleski">I. Durand-Zaleski</name>
<name sortKey="Pauker, S G" sort="Pauker, S G" uniqKey="Pauker S" first="S G" last="Pauker">S G Pauker</name>
<name sortKey="Tsevat, J" sort="Tsevat, J" uniqKey="Tsevat J" first="J" last="Tsevat">J. Tsevat</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005264 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 005264 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Ncbi |étape= Merge |type= RBID |clé= PMC:1349634 |texte= Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:2499200" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a EdenteV2
This area was generated with Dilib version V0.6.32. |